KCT0009446Active, not recruitingUnknown
Small Graft Size and Hepatocellular Carcinoma Outcomes in Adult-to-Adult Living Donor Liver Transplantation: Multicentric Observational Study
Yonsei University Health System, Severance Hospital0 sites2,500 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Unknown
- Status
- Active, not recruiting
- Enrollment
- 2,500
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18(Year) to 80(Year) (—)
- Sex
- All
Inclusion Criteria
- •Patients with hepatocellular carcinoma who received living donor liver transplants from May 2014 to December 2021.
Exclusion Criteria
- •1. Age<18
- •2. Deceased donor liver transplantation
Investigators
Similar Trials
Active, not recruiting
Phase 1
Hepatocellular carcinoma less than 3 cm treated with percutaneous tumour destruction: multicentric phase 2 trial assessing the impact of idarubicin-lipiodol intra-arterial chemotherapy on hepatic recurrence.The research hypothesis is that hepatic locoregional treatment with idarubicin and lipiodol would be an effective adjuvant therapy of hepatocellular carcinomaEUCTR2019-001362-15-FRniversity Hospital of Montpellier138
Completed
Not Applicable
Microvascular invasion of hepatocellular carcinoma predicts microvascular invasion of its recurrence.A potential implication for salvage liver transplantatioC22.0Liver cell carcinomaDRKS00024062Allgemein-, Viszeral- u. Transplantationschirurgie Universitätsmedizin Mainz37
Recruiting
Phase 2
Hepatocellular carcinoma: vascular abnormalities prior to, during and following systemic anti-cancer treatment10019815liver cancerNL-OMON32482eids Universitair Medisch Centrum28
Active, not recruiting
Not Applicable
Hepatocellular carcinoma: vascular abnormalities prior to, during and following systemic anti-cancer treatment - everolimus and capecitabine for HCCEUCTR2008-003972-23-NLMC
Enrolling By Invitation
Not Applicable
Comparison between using hepatocellular carcinoma (HCC) risk scores and current criteria to identify chronic hepatitis B patients needing HCC surveillance-Compare between the use of HCC risk scores and current criteria to identify HCC high risk in chronic hepatitis B patients -Role the HCC risk scores to identify HCC high risk in chronic hepatitis BTCTR20200827002one201